File(s) under permanent embargo

Reason: Under embargo until November 2018. After this date a copy can be supplied under Section 51 (2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library or by emailing

Health Economics Consideration of Personalised Medicine Adoption in Southeast Asia

posted on 02.11.2017, 05:58 by HUEY YI CHONG
The emergence of personalised medicine (PM) indicates a potential transformative point to a greater efficiency in Southeast Asia (SEA)’s healthcare. This research aims to provide PM-related evidence to policymakers, to facilitate an informed adoption decision and improve policies underpinning PM adoption in SEA. Cost-effectiveness evidence was generated for two PM interventions, and the current PM adoption landscape in SEA was described. Adopting PM remains in its infancy in SEA. Local health technology assessment should consider cost-effectiveness evidence and broader societal impacts of PM for an informed decision-making. Substantial future work is needed to support an efficient, equitable PM adoption.


Principal supervisor

Nathorn Chaiyakunapruk

Additional supervisor 1

David Bin-Chia Wu

Year of Award


Department, School or Centre

Jeffrey Cheah School of Medicine and Health Sciences (Monash University Malaysia)

Campus location



Doctor of Philosophy

Degree Type



Faculty of Medicine Nursing and Health Sciences

Usage metrics